Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-04

Clinical Trial Update: PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) [Phase 2]

View source ↗

Summary

Phase 2 PK/PD study update for LUM-201 in children with idiopathic growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUM-201

Snippet

Sponsor: Lumos Pharma | Conditions: Growth Hormone Deficiency | Phase 2 | Status: ACTIVE_NOT_RECRUITING